Design, synthesis and SAR study of bridged tricyclic pyrimidinone carboxamides as HIV-1 integrase inhibitors

被引：8

作者：

Patel, Manoj ^{[1
,5
]}

Naidu, B. Narasimhulu ^{[1
,5
]}

Dicker, Ira ^{[2
,5
]}

Higley, Helen ^{[2
]}

Lin, Zeyu ^{[2
]}

Terry, Brian ^{[2
]}

Protack, Tricia ^{[2
]}

Krystal, Mark ^{[2
,5
]}

Jenkins, Susan ^{[1
,5
]}

Parker, Dawn ^{[1
,5
]}

Panja, Chiradeep ^{[3
]}

Rampulla, Richard ^{[4
]}

Mathur, Arvind ^{[4
]}

Meanwell, Nicholas A. ^{[1
]}

Walker, Michael A. ^{[1
,6
]}

机构：

[1] Dept Discovery Chem & Mol Technol, 5 Res Pkwy, Wallingford, CT 06492 USA

[2] Bristol Myers Squibb Res & Dev, Virol, 5 Res Pkwy, Wallingford, CT 06492 USA

[3] Biocon Bristol Myers Squibb Res Ctr, Plot 2&3,Bommasandra Ind Estate Phase 4, Bengaluru 560099, Karnataka, India

[4] Bristol Myers Squibb Res & Dev, Dept Discovery Chem Synth, POB 4000, Princeton, NJ 08543 USA

[5] ViiV Healthcare, 36 East Ind Pkwy, Branford, CT 06405 USA

[6] Assembly Biosci Inc, 331 Oyster Point Blvd, San Francisco, CA 94080 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2020年 / 28卷 / 13期

关键词：

RALTEGRAVIR RESISTANCE; DOLUTEGRAVIR; ELVITEGRAVIR; MUTATIONS; EVOLUTION;

D O I：

10.1016/j.bmc.2020.115541

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The design, synthesis and structure-activity relationships associated with a series of bridged tricyclic pyrimidinone carboxamides as potent inhibitors of HIV-1 integrase strand transfer are described. Structural modifications to these molecules were made in order to examine the effect on potency towards wild-type and clinically-relevant resistant viruses. The [3.2.2]-bridged tricyclic system was identified as an advantageous chemotype, with representatives exhibiting excellent antiviral activity against both wild-type viruses and the G140S/Q148H resistant virus that arises in response to therapy with raltegravir and elvitegravir. © 2020 Elsevier Ltd

引用

页数：6

共 50 条

[1] Design, synthesis and SAR study of bridged tricyclic pyrimidinone as HIV integrase inhibitors
Patel, Manoj
Naidu, B. Narasimhulu
Dicker, Ira
Hingley, Helen
Lin, Zeyu
Terry, Brian
Protack, Tricia
Meanwell, Nicholas A.
Krystal, Mark
Walker, Michael A.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
[2] Synthesis of styrylquinoline carboxamides for HIV-1 integrase inhibitors
Lee, Seung Uk
Park, Jang Hyun
Lee, Jae Yeol
Shin, Cha-Gyun
Chung, Bong Young
Lee, Yong Sup
BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2006, 27 (11) : 1888 - 1890
[3] Design, synthesis and SAR study of novel spiro aza-pyrimidinone HIV integrase inhibitors
Li, Chen
Walker, Michael A.
Ueda, Yasutsugu
Matiskella, John
Lin, Zeyu
Dicker, Ira
Samanta, Himadri
Terry, Brian
Higley, Helen
Bollini, Sagarika
Krystal, Mark
Meanwell, Nicholas A.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
[4] Design and optimization of tricyclic phtalimide analogues as novel inhibitors of HIV-1 integrase
Verschueren, WG
Dierynck, I
Amssoms, KIE
Hu, LL
Boonants, PMJG
Pille, GME
Daeyaert, FFD
Hertogs, K
Surleraux, DLNG
Wigerinck, PBTP
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) : 1930 - 1940
[5] MEDI 3-Tricyclic HIV-1 integrase inhibitors: SAR studies and preclinical evaluations
Jin, Haolun
Wright, Matthew
Matobo, Sammy
Mish, Michael
Jabri, Salman
Lansdown, Rachael
Fardis, Maria
Cai, Ruby
Pyun, Peter
Pastor, Richard
Schacherer, Laura
Tsiang, Manuel
Chen, Xiaowu
Chen, James
Kim, Choung U.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 235
[6] Effect of substitution on novel tricyclic HIV-1 integrase inhibitors
Fardis, Maria
Jin, Haolun
Jabri, Salman
Cai, Ruby Z.
Mish, Michael
Tsiang, Manuel
Kim, Choung U.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (15) : 4031 - 4035
[7] De novo design and synthesis of HIV-1 integrase inhibitors
Makhija, MT
Kasliwal, RT
Kulkarni, VM
Neamati, N
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (09) : 2317 - 2333
[8] Design, synthesis and biological evaluation of novel tricyclic HIV-1 integrase inhibitors by modification of its pyridine ring
Metobo, Sammy E.
Jin, Haolun
Tsiang, Manuel
Kim, Choung U.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (15) : 3985 - 3988
[9] Design and discovery of HIV-1 integrase inhibitors
Neamati, N
Sunder, S
Pommier, Y
DRUG DISCOVERY TODAY, 1997, 2 (11) : 487 - 498
[10] Design and synthesis of novel pyrimidone analogues as HIV-1 integrase inhibitors
Yu, Shenghui
Sanchez, Tino Wilson
Liu, Yang
Yin, Yanzhen
Neamati, Nouri
Zhao, Guisen
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (22) : 6134 - 6137

← 1 2 3 4 5 →